Inactive

The National Institutes of Health, Clinical Center is conducting a market survey/sources sought to help determine the availability and technical capability of qualified small businesses, veteran-owned... The National Institutes of Health, Clinical Center is conducting a market survey/sources sought to help determine the availability and technical capability of qualified small businesses, veteran-owned small businesses, service disabled veteran-owned small businesses and/or HUBZONE small business capable of serving the needs mentioned below. This market survey/sources sought announcement is not a request for proposals and the Government is not committed to award a contract pursuant to this announcement. The information from this market research is for planning purposes only and will assist the Government in planning its acquisition strategy. This is strictly market research and the Government will not entertain questions concerning this market research. The Government will not pay for any costs incurred in the preparation of information for responding to this market survey. The NIH is seeking a qualified and experienced contractor(s) capable of providing Baxter Corporation manufactured supplies and pharmaceuticals including the following. 0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG Plus Container, VIAFLEX Plastic Container: NDC 0338-0553-18 0.9% Sodium Chloride Injection, USP, 50 mL MINI-BAG Plus Container, VIAFLEX Plastic Container NDC 0338-0553-11 1 liter Saline bags 1000ml TPN Bags 10ml Amber Oral Syringes100/boxItem# H9388510 5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, VIAFLEX Plastic Container: NDC 0338-0551-18. 5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, VIAFLEX Plastic Container. 500ml Exactamix TPN bags Clinisol 15% Amino Acid SF Solution (NDC: 00338-0502-06) EMPTY INTRAVIA CONTAINER 150ML2B8011 EMPTY INTRAVIA CONTAINER 50ML2B8019 Empty INTRAVIA Container with Non-DEHP Fluid Path, 250 mL Empty INTRAVIA Container with Non-DEHP Fluid Path, 500 mL Empty INTRAVIA Container with PVC Ports, Sterile fluid path, 150 mL Empty INTRAVIA Container with PVC Ports, Sterile fluid path, 50 mL Exactamed Oral Dispenser syringes amber color 20 ml Units: BOX Catalog#: 9388120 EXACTAMED Oral Dispenser, Cost-Containment Pack, Amber, Bulk, Tip Caps Included, 10 mL Exactamed Oral Syringes, 35ml Units: CASE Catalog#: H9388135 Exactamed Oral syringes, 60ml Units: CASE Catalog#: H9388160 EXACTAMIX Empty EVA BAG 4000 mLEXACTAMIX Empty EVA BAG 4000 mL. Single Use Only. Fluid path is sterile and non-pyrogenic. Exactamix Empty EVA bags 250mL Exactamix Empty EVA bags 500mL Exactamix EVA Bag 500ml 50 EA/CS H938738 Fibrin Sealant Tisseel 10 mL, Vapor Heated, Solvent/Detergent Treated, Frozen Fibrin Sealant TISSEEL 4ml pre-fill syringes vapor heated, solvent/detergent treated, frozen Fibrin Sealant Tisseel 4mL, Vapor Heated, Solvent/Detergent Treated, Frozen H9385106 - ADAPTACAP Bottle Adapter, Threaded, Tethered and Re-closable Cap, fits 28 mm long neck bottles. 100 caps per case.Ordering 5 cases, $61.55 per case. Mannitol 5% USP for Injection(Osmitrol) 1000ml 2D5604XNDC: 0338-0351-04 Non Venting high volume tubing Catalog # H938173 NON-DEHP FLUID PATH INTRAVIA CONTAINER 250ML2J8002 Pharmacy Pack Amber 10ml 500 Item# H9388510 Units: CASE Catalog#: H9388510 Prismasol 2/0 Prismasol B22GK4/0 NDC 24571-111-06 PrismaSol BGK 0/2.5 PrismaSol BGK 4/0/1.2 Sterile EXACTAMIX 2400 Valve Set. Connects up to 24 Source Ingredients. Catalog#: H938724 SUPOR Syringe Filter, 1.2 Micron, 32mm, Female Luer Lock Connector, Male Luer Lock Connector, Clear/Blue. Sterile. EXACTAMIX TPN 3000ml bags Vented micro inlet tubing Catalog # H938175 The Contractor must be capable of delivering ordered supplies within 72 hours of receipt of orders to the National Institutes of Health, 9000 Rockville Pike, Bethesda, MD. The Baxter Healthcare Corporation manufactured supplies and pharmaceuticals will be used for patient care. It is vital that the Contractor provides data with each ordered supply and pharmaceutical in compliance with the Drug Supply Chain Security Act. It is critical that the supplies be deliverable within 72 hours of receipt of order. The vendor responses must demonstrate their experience in the areas described above. Please note that failure to specifically demonstrate past performance and experience with your capability to provide the required supplies in your response to this market survey may affect the Government's review of industry's ability to supply them. The vendor's response shall be in sufficient detail to allow the Government to assess the capability of your firm. The vendor response shall also include any other specific and relevant information related to the requirements of this project that will enable the Government to determine the capabilities of the company to perform the specialized requirements described in this synopsis. Interested organizations must demonstrate and document in any response submitted to this market survey extensive experience with and the ability to perform all of the specialized requirements elsewhere described. This notice is a market survey and is for information and planning purposes only and does not commit the Government to any contractual agreement. THIS IS NOT A REQUEST FOR PROPOSALS. The Government will not award a Purchase Order or Contract based upon Vendor responses to this announcement. The Government shall not assume any costs for preparing or submitting any information in response to the market survey or the Government's use of the information. Any proprietary information should be clearly identified as "proprietary information". In addition to addressing the requirements in the attached SOW, the Government requests that your capability statement address the following requests for information, if relevant. 1) Please provide the full company/entity name, address including points of contact (phone number and e-mail address), DUNS numbers, and type/size of the company/entity by NAICS code. 2) If your company/entity is a dealer or service-provider, and not a manufacturer of the end items/products contemplated by the SOW, please identify your company as such and identify the end item/product manufacturers that you would be obtaining goods from in order to perform the contract, and where the manufacturers are geographically located. 3) According to the small business limitations on subcontracting standard provided by the amended Small Business Act at 15 U.S.C. § 657s, the requirement for a small business supplier is that the small business prime contractor "may not expend on subcontractors more than 50 percent of the amount, less the cost of materials, paid to the concern under the contract . . . ." 15 U.S.C. § 657s(a)(2). However, "[c]ontract amounts expended by a covered small business concern on a subcontractor that is a similarly situated entity [(i.e., another small/small disadvantaged business of the same type)] shall not be considered subcontracted for purposes of determining whether the covered small business concern has violated [limitations on subcontracting.]" 15 U.S.C. § 657s(b). If you are a small business, please address your ability to adhere to limitations on subcontracting at 15 U.S.C. § 657s. To ascertain if you are a small business, use the size standard provided by NAICS Code 325412 (pharmaceutical preparation manufacturing), with a size standard of no more than 1250 employees. As part of this, if you are a small business that is a dealer/service-provider and not a manufacturer, please so state, and address whether you meet the following requirements from 13 C.F.R. § 121.406(b). Specifically, your company/entity: (1) Does not exceed 500 employees (notice that the employee standard under the non-manufacturer rule is more restrictive than for NAICS Code 325412); (2) Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; (3) Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice; and (4) Will supply the end item of a small business manufacturer, processor, or producer made in the United States. NIH must receive written capability statements no later than September 13 at 9:00 a.m. Eastern Time. E-mail the written capability statement to Lisa Schaupp, the Contract Specialist, at the e-mail address Lisa.Schaupp@nih.gov. Respondents will NOT be notified as to the results of the Government's market research.